Description of 3,180 Courses of Chelation with Dimercaptosuccinic Acid in Children ≤5 y with Severe Lead Poisoning in Zamfara, Northern Nigeria: A Retrospective Analysis of Programme Data

Jane Greig and colleagues from the medical humanitarian organization Médecins Sans Frontières describe the use of the oral chelating agent dimercaptosuccinic acid (DMSA) in several thousand young children with severe lead poisoning as a result of an environmental disaster in Zamfara, northern Nigeria. Please see later in the article for the Editors' Summary

[1]  K. Caldwell,et al.  Analysis of a novel field dilution method for testing samples that exceed the analytic range of point-of-care blood lead analyzers , 2014, International journal of environmental health research.

[2]  P. Dargan,et al.  Association of Blood Lead Level with Neurological Features in 972 Children Affected by an Acute Severe Lead Poisoning Outbreak in Zamfara State, Northern Nigeria , 2014, PloS one.

[3]  Ord,et al.  Guidance on Selecting Age Groups for Monitoring and Assessing Childhood Exposures to Environmental Contaminants , 2013 .

[4]  Sophia Rabe-Hesketh,et al.  Multilevel and Longitudinal Modeling Using Stata, Volumes I and II, Third Edition: Multilevel and Longitudinal Modeling Using Stata, Volume II ... Counts, and Survival, Third Edition , 2012 .

[5]  Nasir Sani-Gwarzo,et al.  Outbreak of Fatal Childhood Lead Poisoning Related to Artisanal Gold Mining in Northwestern Nigeria, 2010 , 2011, Environmental health perspectives.

[6]  M. Kosnett Chelation for Heavy Metals (Arsenic, Lead, and Mercury): Protective or Perilous? , 2010, Clinical pharmacology and therapeutics.

[7]  Y. Amitai,et al.  Lead poisoning among internally displaced Roma, Ashkali and Egyptian children in the United Nations-Administered Province of Kosovo. , 2010, European journal of public health.

[8]  A. Vale,et al.  A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning , 2009, Clinical toxicology.

[9]  A. Vale,et al.  Use of oral dimercaptosuccinic acid (succimer) in adult patients with inorganic lead poisoning. , 2009, QJM : monthly journal of the Association of Physicians.

[10]  A. Vale,et al.  Dimercaptosuccinic acid (succimer; DMSA) in inorganic lead poisoning , 2009, Clinical toxicology.

[11]  Shunqin Wang,et al.  Blood lead levels of children and its trend in China. , 2009, The Science of the total environment.

[12]  R. Bertollini,et al.  Mass Lead Intoxication from Informal Used Lead-Acid Battery Recycling in Dakar, Senegal , 2009, Environmental health perspectives.

[13]  Sophia Rabe-Hesketh,et al.  Multilevel and longitudinal modeling using Stata. 2nd edition , 2008 .

[14]  S. Kales,et al.  Lead encephalopathy due to traditional medicines. , 2008, Current drug safety.

[15]  M. Brown,et al.  Evaluation and recommendations for preventing lead poisoning among the internally displaced Roma population in Kosovo from the Centers for Disease Control and Prevention , 2007 .

[16]  N. Horton Multilevel and Longitudinal Modeling Using Stata , 2006 .

[17]  African Lungfish,et al.  Standard operating procedures , 2006, Nature Biotechnology.

[18]  Death of a child after ingestion of a metallic charm--Minnesota, 2006. , 2006, MMWR. Morbidity and mortality weekly report.

[19]  Monica Cheesbrough,et al.  District Laboratory Practice in Tropical Countries: Acknowledgements , 2005 .

[20]  J. Gibson,et al.  A Plea for Painted Railings and Painted Walls of Rooms as the Source of Lead Poisoning Amongst Queensland Children , 2005, Public health reports.

[21]  J. Brent Critical care toxicology : diagnosis and management of the critically poisoned patient , 2005 .

[22]  Catherine Anne Kelly,et al.  Comparison of consciousness level assessment in the poisoned patient using the alert/verbal/painful/unresponsive scale and the Glasgow Coma Scale. , 2004, Annals of emergency medicine.

[23]  J. Coresh,et al.  Blood lead and chronic kidney disease in the general United States population: results from NHANES III. , 2003, Kidney international.

[24]  Catherine J Staes,et al.  Deaths related to lead poisoning in the United States, 1979-1998. , 2003, Environmental research.

[25]  J. R. Reigart,et al.  The Effect of Chelation Therapy With Succimer on Neuropsychological Development in Children Exposed to Lead , 2003 .

[26]  B. Harvey Managing elevated blood lead levels among young children : recommendations from the Advisory Committee on Childhood Lead Poisoning Prevention , 2002 .

[27]  S. Rothenberg,et al.  The lead content of blood serum. , 2001, Environmental research.

[28]  Robert L. Jones,et al.  The effect of chelation therapy with succimer on neuropsychological development in children exposed to lead. , 2001, The New England journal of medicine.

[29]  A. Onalaja,et al.  Genetic susceptibility to lead poisoning. , 2000, Environmental health perspectives.

[30]  J. Chisolm,et al.  Safety and Efficacy of Meso-2,3-Dimercaptosuccinic Acid (DMSA) in Children with Elevated Blood Lead Concentrations , 2000, Journal of toxicology. Clinical toxicology.

[31]  Safety and efficacy of succimer in toddlers with blood lead levels of 20-44 microg/dL. Treatment of Lead-Exposed Children (TLC) Trial Group. , 2000, Pediatric research.

[32]  George G. Rhoads,et al.  Safety and Efficacy of Succimer in Toddlers with Blood Lead Levels of 20–44 μg/dL , 2000, Pediatric Research.

[33]  W. Rogan,et al.  Treatment of Lead-Exposed Children (TLC) Trial: Effect of Succimer in Toddlers with Blood Leads of 20-44 µg/dl , 1999 .

[34]  K. White,et al.  A Comparison of Two Dosing Regimens of Succimer in Children with Chronic Lead Poisoning , 1999, Journal of clinical pharmacology.

[35]  The Treatment of Lead-exposed Children (TLC) trial: design and recruitment for a study of the effect of oral chelation on growth and development in toddlers. , 1998, Paediatric and perinatal epidemiology.

[36]  I. Bergdahl,et al.  Lead concentrations in human plasma, urine and whole blood. , 1997, Scandinavian journal of work, environment & health.

[37]  E. Prado [The importance of eosinophils in children with bronchial asthma]. , 1997, Jornal de pediatria.

[38]  Michigan.,et al.  Toxicological profile for dichloropropenes , 2008 .

[39]  P. Bijur,et al.  Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. , 1996, Environmental health perspectives.

[40]  J. Graziano,et al.  Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. , 1995, Environmental health perspectives.

[41]  D. Notterman,et al.  Treatment Guidelines for Lead Exposure in Children , 1995, Pediatrics.

[42]  K. Hurlbut,et al.  Pharmacokinetics of meso-2,3-dimercaptosuccinic acid in patients with lead poisoning and in healthy adults. , 1994, The Journal of pediatrics.

[43]  M. Shannon,et al.  Efficacy of oral meso-2,3-dimercaptosuccinic acid therapy for low-level childhood plumbism. , 1994, The Journal of pediatrics.

[44]  B. Dean,et al.  Ceramic lead glaze ingestions in nursing home residents with dementia. , 1994, The American journal of emergency medicine.

[45]  V. Slavkovich,et al.  Controlled study of meso-2,3-dimercaptosuccinic acid for the management of childhood lead intoxication. , 1992, The Journal of pediatrics.

[46]  J. Chisolm,et al.  Evaluation of the potential role of chelation therapy in treatment of low to moderate lead exposures. , 1990, Environmental health perspectives.

[47]  J. Graziano,et al.  Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. , 1988, The Journal of pediatrics.

[48]  J. Graziano,et al.  Dose-response study of oral 2,3-dimercaptosuccinic acid with elevated blood lead concentrations in children , 1988 .

[49]  D. Moel,et al.  Slow, natural reduction in blood lead level after chelation therapy for lead poisoning in childhood. , 1986, American journal of diseases of children.

[50]  D. Altman,et al.  STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT , 1986, The Lancet.

[51]  J. Graziano,et al.  2,3‐Dimercaptosuccinic acid as an antidote for lead intoxication , 1985, Clinical pharmacology and therapeutics.

[52]  D. E. Carter,et al.  DMSA, DMPS, and DMPA--as arsenic antidotes. , 1984, Fundamental and applied toxicology : official journal of the Society of Toxicology.

[53]  J. Chisolm The use of chelating agents in the treatment of acute and chronic lead intoxication in childhood. , 1968, The Journal of pediatrics.

[54]  W. Staples,et al.  Treatment of lead encephalopathy in children. , 1966, The Journal of pediatrics.

[55]  Wang Sc,et al.  Chelating therapy with Na-DMS in occupational lead and mercury intoxications. , 1965 .

[56]  J. Greengard,et al.  ACUTE LEAD ENCEPHALOPATHY IN YOUNG CHILDREN. , 1965, The Journal of pediatrics.

[57]  S. C. Wang,et al.  Chelating therapy with Na-DMS in occupational lead and mercury intoxications. , 1965, Chinese medical journal.

[58]  J. Chisolm,et al.  The treatment of acute lead encephalopathy in children. , 1957, Pediatrics.

[59]  A. Merklen,et al.  [Lead poisoning]. , 1956, Revue medicale de Nancy.

[60]  F. Rieders,et al.  The efficacy of edathamil calcium disodium in the treatment of occupational lead poisoning. , 1955, Industrial medicine & surgery.

[61]  H. Harrison,et al.  Treatment of lead encephalopathy with PAL (2.3-dimercaptopropanol). , 1950, Pediatrics.

[62]  E. Kaplan,et al.  Incidence of Lead Poisoning in the City of Baltimore. , 1942 .